# Cost Effectiveness of Fremanezumab in Episodic and Chronic Migraine Patients from a Japanese Healthcare Perspective

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/cost-effectiveness-of-fremanezumab-in-episodic-and-chronic-migraine-patients/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Takao Takeshima,Fumihiko Sakai,Xinyu Wang,Kentaro Yamato,Yoshitsugu Kojima,Yilong Zhang,Craig Bennison,Martijn Simons |
| Citations | 6 |
| DOI | 10.1007/s40273-024-01380-0 |
| Fields | Medicine,Neuroscience |
| Open Access | true |
| OA Status | hybrid |
| OA URL | https://link.springer.com/content/pdf/10.1007/s40273-024-01380-0.pdf |
| OpenAlex ID | https://openalex.org/W4398165449 |
| PMID | 38771521 |
| Type | article |
| Year | 2024 |

## Paper authors

- [Yoshitsugu Kojima](https://scholariq.org/researchers/yoshitsugu-kojima/)

## Paper journal

- [PharmacoEconomics](https://scholariq.org/journals/pharmacoeconomics/)

## Paper primary topic

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)

## Paper topics

- [Migraine and Headache Studies](https://scholariq.org/topics/migraine-and-headache-studies/)
- [Vestibular and auditory disorders](https://scholariq.org/topics/vestibular-and-auditory-disorders/)
- [Parkinson's Disease Mechanisms and Treatments](https://scholariq.org/topics/parkinson-s-disease-mechanisms-and-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.